Clinical Trials Logo

Clinical Trial Summary

The goal of this clinical trial is to test the safety and effectiveness of an injection study drug in decreasing bilateral flank adiposity. The main question it aims to answer is: •How safe and effective is the injection study drug in removing bilateral flank adiposity compared to a placebo? Participants will be: - Be given injections every month for 5 months over the right and left flanks. - Be asked to be seen in the clinic for 13 visits and 3 phone call visits during a duration of 1 year.


Clinical Trial Description

Fifteen subjects with bilateral flank adiposity will be enrolled across 1-3 sites in the USA. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05760248
Study type Interventional
Source 10xBio, LLC
Contact
Status Active, not recruiting
Phase Phase 2
Start date May 4, 2023
Completion date December 26, 2024

See also
  Status Clinical Trial Phase
Withdrawn NCT04090853 - Subject Evaluation of a 1064nm Diode Laser/RF N/A
Completed NCT05155683 - Combination of Light and Ultrasound to Reduce Abdominal Fat N/A
Completed NCT03033004 - Cryolipolisis for Abdomen and Flank Fat Reduction N/A